Organisation paid for research Program year 2024 Source: CMS Open Payments

Bioscience Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$493,572

64 payments

Through program year 2024, Bioscience Research, LLC is reported as receiving $493,572 in research payments, across 64 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$300,145	18
2023	Research	$115,153	10
2022	Research	$16,160	1
2020	Research	$2,666	5
2019	Research	$59,448	30

Breakdown

Who paid Research payments · program years 2019–2024

Axsome Therapeutics, Inc. $297,645 16 payments
F. Hoffmann-La Roche AG $133,813 13 payments
Sunovion Pharmaceuticals Inc. $59,448 30 payments
Alkermes, Inc. $2,666 5 payments

Studies the money was for Research payments · program years 2019–2024

A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive Symptoms $297,645 16 payments
P2 Study of Balovaptan in PTSD $133,813 13 payments
Dasotraline Binge Eating Disorder Extension Study $59,436 28 payments
A Phase 3b Extension Study of Adjunctive ALKS5461 in the Treatment of Refractory Major DepressiveDisorder $2,456 2 payments
A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder $210 3 payments
Pediatric Open-Label Extension Study $13 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.